• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Skin Irritation (2076); Patient Problem/Medical Problem (2688)
Event Date 06/11/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician used a venaseal closure system to treat the distal leg great saphenous vein(gsv) on (b)(6) 2019.There were no issues reported during the procedure itself.It was reported that on (b)(6) 2019, irritation began along the treated vein segment and by (b)(6) blisters have started to form.The patient was prescribed keflex and steroids.
 
Manufacturer Narrative
The patient¿s lower right gsv (sfj to above knee where previous rf ablation was performed) was treated.Compression was not used.The patient reported a red, hot swollen leg.The patient was requested to mark the edges.Patient took benadryl and used ice.Patient returned for follow-up 3 days post procedure.The vein was reported to be closed.The erythema had spread from the original marked area.The skin was reported to be warm and very painful.Patient was prescribed nsaid¿s.Patient was prescribed a medrol dose pack for blister formation and improvement was seen in 24 hours.The patient returned 12 days later with worsening erythema and pain.The patient was prescribed another medrol dose pack.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: the issue has resolved.The patient is no longer experiencing symptoms after the medrol dose pack.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8707440
MDR Text Key148285980
Report Number9612164-2019-02397
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 07/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2020
Device Catalogue NumberVS-402
Device Lot Number52797
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/15/2019
Date Device Manufactured09/13/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient Weight59
-
-